13D Filing: Coliseum Capital and Bioscrip Inc. (BIOS)

Page 1 of 10

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Coliseum Capital Management 0 24,208,030 0 24,208,030 24,208,030 16.5%
Coliseum Capital 8. 18,629,734 0 18,629,734 18,629,734 13.1%
Coliseum Capital Partners 0 15,204,502 0 15,204,502 15,204,502 10.9%
Coliseum Capital Partners II 0 3,425,232 0 3,425,232 3,425,232 2.6%
Adam Gray 0 24,208,030 0 24,208,030 24,208,030 16.5%
Christopher Shackelton 0 24,208,030 0 24,208,030 24,208,030 16.5%

Follow Christopher Shackelton And Adam Gray's Coliseum Capital

Page 1 of 10 – SEC Filing



Washington, D.C. 20549




Under the Securities Exchange Act of 1934*

(Amendment No. 4)




(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)


(CUSIP Number)

Christopher Shackelton/Adam Gray

105 Rowayton Ave.

Rowayton, CT 06853

Address and Telephone Number of Person Authorized to Receive Notices and Communications)

August 17, 2017

(Date of Event Which Requires Filing of this Statement)



If the filing person has
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of sections 240.13d-1(e),
240.13d-1(f) or 140.13d-1(g), check the following box.  ☐

The information required on the remainder of
this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).

Follow Option Care Health Inc. (NASDAQ:OPCH)

Page 1 of 10